Drug Development Regulatory Path Services
BRC provides pharmaceutical regulatory consulting for development and comprehensive management of preclinical and clinical drug development programs, as well as for special projects relating to drug safety, preclinical and clinical trial design, drug labeling, submissions among others. ​ 

Drug Regulatory Affairs - Overview

​BRC defines reliable and credible drug regulatory paths, and provides associated services, to get your product to market successfully.  

Preclinical & Clinical Regulatory Consulting

BRC applies its clinical expertise to create and map robust and appropriately lean preclinical and clinical programs that are informed by FDA feedback. ​ 

CMC Regulatory Affairs
​

BRC partners to deliver patented AI synthesis, GLP test materials, GMP formulations, stability, and technical transfer for scale-up and manufacture, at competitive rates. ​